Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

570
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
570
Tumor Immunotherapy01:27

Tumor Immunotherapy

659
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
659
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Urinary Bladder01:23

Urinary Bladder

1.4K
The urinary bladder is a hollow, muscular sac that temporarily stores urine before it is expelled from the body. It can hold approximately 600 mL of urine prior to micturition. The bladder is retroperitoneal and located behind the pubic symphysis in the pelvic floor.
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...
1.4K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Prognostic value of the Duke Activity Status Index for preoperative cardiac risk stratification: an international pooled cohort study.

EClinicalMedicine·2026
Same author

Association of anesthesiologists' hepato-pancreato-biliary volume and outcomes for other surgeries.

HPB : the official journal of the International Hepato Pancreato Biliary Association·2026
Same author

Hospital Policy of Tranexamic Acid to Reduce Transfusion in Major Noncardiac Surgery.

The New England journal of medicine·2026
Same author

Frailty Status and Preoperative Cardiac Risk Stratification in Older Adults Undergoing Noncardiac Surgery: A Multicenter Prospective Cohort Study.

Journal of the American Heart Association·2026
Same author

Comparison of partial nephrectomy to radical nephrectomy for non-metastatic cT2 renal tumors: Results from a Canadian Multi-Institutional Collaborative.

Urologic oncology·2026
Same author

Association between model of anesthesiology care and outcomes after cataract surgery: a population-based cohort study.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2026
Same journal

<sup>177</sup>Lu-PSMA-617 in a Canadian universal healthcare system.

Canadian Urological Association journal = Journal de l'Association des urologues du Canada·2026
Same journal

From one chapter to the next Reflections on the CUA presidency.

Canadian Urological Association journal = Journal de l'Association des urologues du Canada·2026
Same journal

Notes on a crisis and professional life.

Canadian Urological Association journal = Journal de l'Association des urologues du Canada·2026
Same journal

Advocating for policy that promotes and maintains urologists of all genders.

Canadian Urological Association journal = Journal de l'Association des urologues du Canada·2026
Same journal

Randomized, multicenter trial of ureteral stent placement vs. stent omission after ureteroscopy for renal stones.

Canadian Urological Association journal = Journal de l'Association des urologues du Canada·2026
Same journal

The five amigos: Training and practicing under the living titans of Queen's Urology.

Canadian Urological Association journal = Journal de l'Association des urologues du Canada·2026
Ver todos los artículos relacionados

Video Experimental Relacionado

Updated: Sep 9, 2025

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

21.4K

Terapia de reemplazo de testosterona y cáncer de vejiga

Mikael F Kanaan1, Rodney H Breau1,2, Luke T Lavallée1,2

  • 1University of Ottawa, Ottawa, ON, Canada.

Canadian Urological Association journal = Journal de l'Association des urologues du Canada
|September 2, 2025
PubMed
Resumen
Este resumen es generado por máquina.

La testosterona preoperatoria puede ayudar a los pacientes con cáncer de vejiga al prevenir la pérdida de músculo y mantener los recuentos sanguíneos después de la cirugía. Esta intervención barata podría mejorar la recuperación con pocos efectos secundarios, lo que justifica ensayos clínicos.

Más Videos Relacionados

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.2K
An Orthotopic Bladder Cancer Model for Gene Delivery Studies
07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

12.6K

Videos de Experimentos Relacionados

Last Updated: Sep 9, 2025

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

21.4K
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.2K
An Orthotopic Bladder Cancer Model for Gene Delivery Studies
07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

12.6K

Área de la Ciencia:

  • En el campo de la oncología
  • Endocrinología

Sus antecedentes:

  • El tratamiento del cáncer de vejiga invasivo muscular incluye quimioterapia neoadyuvante y cistectomía radical, que tienen una morbilidad significativa.
  • Los tratamientos actuales pueden conducir a la atrofia del músculo esquelético, a la reducción de la masa corporal y a una gran pérdida de sangre que requiere transfusión.
  • El papel de los andrógenos en el cáncer de vejiga no se comprende bien, con datos contradictorios sobre las terapias antiandrógenas.

Objetivo del estudio:

  • Para presentar una justificación para el uso de testosterona preoperatoria en pacientes con cáncer de vejiga invasivo muscular.
  • Explorar los beneficios potenciales de la testosterona para mitigar los efectos secundarios relacionados con el tratamiento.
  • Para sentar las bases para un futuro ensayo clínico investigando la testosterona preoperatoria en esta población de pacientes.

Principales métodos:

  • Este es un artículo de revisión, no un estudio experimental.
  • Los autores presentan una base teórica y pruebas de apoyo para la intervención propuesta.
  • La revisión sintetiza los conocimientos existentes sobre andrógenos, cáncer y recuperación quirúrgica.

Principales resultados:

  • Se supone que la testosterona preoperatoria previene la atrofia del músculo esquelético asociada con la quimioterapia neoadyuvante.
  • La testosterona puede ayudar a mantener niveles normales de hematocrito, reduciendo potencialmente la necesidad de transfusiones de sangre durante la cistectomía radical.
  • La intervención se considera barata, factible y asociada con efectos adversos mínimos en otros grupos de pacientes.

Conclusiones:

  • La testosterona preoperatoria presenta una estrategia prometedora y de bajo costo para mejorar los resultados en pacientes con cáncer de vejiga invasivo muscular.
  • Se necesitan ensayos clínicos adicionales para validar la eficacia y seguridad de la testosterona preoperatoria en este tipo específico de cáncer.
  • Este enfoque podría mejorar la recuperación postoperatoria y reducir las complicaciones relacionadas con el tratamiento.